Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
One Percent Rule Checklist For Safer Forex Trading Risk 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
NEW YORK, April 14, 2017 -- Safirstein Metcalf LLP announces that a class action complaint was filed against DaVita Inc. (“DaVita”) (NYSE:DVA) in the U.S. District Court for the District of Colorado. The complaint is brought on behalf of all purchasers of DaVita securities between August 5, 2015 and October 21, 2016 (the “Class Period”) for alleged violations of the Securities Exchange Act of 1934. Safirstein Metcalf is investigating potential breaches of fiduciary duty by management of DaVita resulting from allegations that management may have issued materially misleading business information to the investing public.
If you would like more information about this matter, please contact Sheila Feerick at 1-800-221-0015, or email [email protected].
According to the Complaint, throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) DaVita and its senior executives purposefully steered patients into needless insurance plans to maximize profits; (2) DaVita was using the American Kidney Fund to facilitate these inappropriate practices; (3) therefore DaVita’s revenues and profits were illegally acquired; (4) as a result, DaVita lacked effective internal controls over financial reporting.
About Safirstein Metcalf LLP
Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection. All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.
Attorney advertising. Prior results do not guarantee a similar outcome.
Safirstein Metcalf LLP Peter Safirstein, Esq. 1250 Broadway 27th Floor New York, NY 10001 1-800-221-0015
